Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | APEX1 | P27695 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NOS3 | P29474 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | NOS2 | P35228 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 7-Nitroindazole SCHEMBL4297994 | 0.98 | NOS1 (0.97) | NOS1MAPTTDP1APEX1CYP3A4 | |
| 7-Nitroindazole SCHEMBL4297993 | 0.98 | NOS1 (0.97) | NOS1MAPTTDP1APEX1CYP3A4 | |
| SCHEMBL15796932 | 0.85 | NOS1 (0.74) | NOS1MAPTTDP1APEX1CYP3A4 | |
| 7-Nitroindazole SCHEMBL3722668 | 0.85 | NOS1 (0.72) | NOS1MAPTTDP1APEX1CYP3A4 | |
| SCHEMBL10594465 | 0.82 | NOS1 (0.69) | NOS1MAPTTDP1APEX1CYP3A4 | |
| SCHEMBL13039512 | 0.82 | NOS1 (0.70) | NOS1MAPTTDP1APEX1CYP3A4 | |
| SCHEMBL4717435 | 0.78 | NOS1 (0.64) | NOS1MAPTTDP1APEX1CYP3A4 | |
| Indazole SCHEMBL27970405 | 0.77 | IDO1 (0.66) | NOS1MAPTTDP1APEX1CYP3A4 | |
| SCHEMBL10595306 | 0.77 | MAPT (0.61) | NOS1MAPTTDP1APEX1CYP3A4 | |
| SCHEMBL11576655 | 0.76 | NOS1 (0.61) | NOS1MAPTTDP1APEX1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083844-A1 | DOWNREGULATING INOS TO INCREASE CAR-T KILLING | H LEE MOFFITT CANCER CT & RES (US) | 2026-03-26 | — | — | US | claimed |
| EP-4709378-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2026-03-18 | — | — | EP | claimed |
| US-20250276085-A1 | SYNTHETIC MULTIDOMAIN PEPTIDE BIOMATERIALS THAT INHIBIT INDUCIBLE NITRIC OXIDE SYNTHASE | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-09-04 | — | — | US | claimed |
| US-20250255850-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2025-08-14 | — | — | US | claimed |
| CN-119223101-A | Environment-friendly airport bird repellent bomb | 中北大学 | 2024-12-31 | — | — | CN | claimed |
| WO-2024231899-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-11-14 | — | — | WO | claimed |
| WO-2024224296-A2 | TARGETED PHARMACEUTICAL COMPOSITIONS TO TREAT NEUROLOGICAL CONDITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-10-31 | — | — | WO | claimed |
| US-20240316006-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-09-26 | — | — | US | claimed |
| WO-2024059834-A2 | DOWNREGULATING INOS TO INCREASE CAR-T KILLING | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (US) | 2024-03-21 | — | — | WO | claimed |
| WO-2023092175-A1 | NOVEL P2X7 RECEPTOR ANTAGONISTS | THE UNIVERSITY OF SYDNEY (AU) | 2023-06-01 | — | — | WO | claimed |
| EP-0769904-A1 | METHOD FOR TREATING ANXIETY | Dunn, Robert W (US) | 1997-05-02 | — | — | EP | claimed |
| WO-1997015280-A1 | USE OF AT LEAST ONE NO SYNTHASE INHIBITOR FOR TREATING SENSITIVE SKIN | L'OREAL (FR) | 1997-05-01 | — | — | WO | claimed |
| EP-0765668-A1 | Extract of Iridaceas and composition containing it | L'OREAL (FR) | 1997-04-02 | — | — | EP | claimed |
| WO-1997009032-A1 | UTILIZATION OF AN EXTRACT OF A NON PHOTOSYNTHETIC FILAMENTARY BACTERIUM AND COMPOSITION CONTAINING SUCH EXTRACT | L'OREAL (FR) | 1997-03-13 | — | — | WO | claimed |
| WO-1997009056-A1 | EXTRACT OF IRIDACEAE AND COMPOSITIONS CONTAINING SUCH EXTRACT | L'OREAL (FR) | 1997-03-13 | — | — | WO | claimed |
| EP-0761204-A1 | Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them | L'OREAL (FR) | 1997-03-12 | — | — | EP | claimed |
| WO-1996021445-A1 | METHODS OF INHIBITING NEURODEGENERATIVE DISEASES | THE GENERAL HOSPITAL CORPORATION (US) | 1996-07-18 | — | — | WO | claimed |
| WO-1996002139-A1 | METHOD FOR TREATING ANXIETY | DUNN ROBERT W (US) | 1996-02-01 | — | — | WO | claimed |
| US-5459158-A | Nitric oxide synthase inhibitors; neurodegenerative diseases | BURROUGHS WELLCOME CO. (US) | 1995-10-17 | — | — | US | claimed |
| US-5441982-A | Administering nitric oxide synthase inhibitor | ITZHAK YOSSEF (US) | 1995-08-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083844-A1 | DOWNREGULATING INOS TO INCREASE CAR-T KILLING | NOS2, NOS1, NOS3 | NOS1 2/4885MAPT 2165/4885TDP1 2862/4885 |
| US-20240316006-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | NLN, ACHE, SMN1; SMN2 | NOS1 28/4885MAPT 33/4885TDP1 599/4885 |
| US-20250255850-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | NLN, ACHE, PYGB | NOS1 18/4885MAPT 40/4885TDP1 567/4885 |
| US-20250276085-A1 | SYNTHETIC MULTIDOMAIN PEPTIDE BIOMATERIALS THAT INHIBIT INDUCIBLE NITRIC OXIDE SYNTHASE | STING1, CGAS, GMPS | NOS1 4/4885MAPT 4516/4885TDP1 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.